The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 28, 2014

Filed:

Aug. 01, 2008
Applicants:

John A. Secrist, Iii, Birmingham, AL (US);

Steven Ealick, Ithaca, NY (US);

Shridhar Bale, Ithaca, NY (US);

Anthony E. Pegg, Hershey, PA (US);

Diane E. Mccloskey, Hershey, PA (US);

Wayne C. Guida, St. Pete Beach, FL (US);

Inventors:

John A. Secrist, III, Birmingham, AL (US);

Steven Ealick, Ithaca, NY (US);

Shridhar Bale, Ithaca, NY (US);

Anthony E. Pegg, Hershey, PA (US);

Diane E. McCloskey, Hershey, PA (US);

Wayne C. Guida, St. Pete Beach, FL (US);

Assignees:

Southern Research Institute, Birmingham, AL (US);

Cornell University, Ithica, NY (US);

H. Lee Moffitt Cancer and Research Institute, Tampa, FL (US);

The Penn State Research Foundation, University Park, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); C07H 19/167 (2006.01); C07H 19/173 (2006.01);
U.S. Cl.
CPC ...
Abstract

The crystal structure of the complex of S-adenosylmethionine methyl ester with hΛdoMetDC F223A, a mutant where the stacking of the aromatic rings of F7, adenine and F223 would be eliminated. The structure of this mutant with the ester shows that the ligand still maintains a syn conformation aided by pi-pi interactions to F7, hydrogen bonds to the backbone of Glu67, and electrostatic interactions. Several series of AdoMet substrate analogues with a variety of substituents at the 8 position of adenine were synthesized and analyzed for their ability to inhibit hAdoMetDC. To understand these results, virtual modeling of the enzyme inhibitor complexes and the crystal structures of human AdoMetDC with 5'-deoxy-5′-[N-methyl-N-[2-(aminooxy)ethyl]amino-8-methyl]adenosine (MAOEMA) and 5′-deoxy-5′-[N-methyl-N-[4-(aminooxy)butyl]amino-8-ethyl]adenosine (MAOBEA) at the active site have been determined experimentally.


Find Patent Forward Citations

Loading…